Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model

CLAIRE M. MACH, LATA MATHEW, SCOTT A. MOSLEY, RAZELLE KURZROCK and JUDITH A. SMITH
Anticancer Research June 2009, 29 (6) 1895-1899;
CLAIRE M. MACH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LATA MATHEW
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SCOTT A. MOSLEY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAZELLE KURZROCK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JUDITH A. SMITH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jasmith@mdanderson.org
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 6 1895-1899
PubMed 
19528445

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received March 6, 2009
  • Accepted April 29, 2009
  • Published online June 15, 2009.

Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. CLAIRE M. MACH1,
  2. LATA MATHEW1,
  3. SCOTT A. MOSLEY2,
  4. RAZELLE KURZROCK3 and
  5. JUDITH A. SMITH1,2,4
  1. 1Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
  2. 2Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
  3. 3Division of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, U.S.A.
  4. 4Department of Obstetrics, The University of Texas Health Science Center, Gynecology and Reproductive Sciences, Houston, TX, U.S.A.
  1. Correspondence to: Judith A. Smith, Ph.D., BCOP, FCCP, FISOPP, Department of Gynecologic Oncology, Division of Surgery, P.O. Box 301439-UNIT 1362, Houston, Texas 77230-1439, U.S.A. Tel: +713 5006408, Fax: +713 5005474, e-mail: jasmith{at}mdanderson.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 29 (6)
Anticancer Research
Vol. 29, Issue 6
June 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model
CLAIRE M. MACH, LATA MATHEW, SCOTT A. MOSLEY, RAZELLE KURZROCK, JUDITH A. SMITH
Anticancer Research Jun 2009, 29 (6) 1895-1899;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Determination of Minimum Effective Dose and Optimal Dosing Schedule for Liposomal Curcumin in a Xenograft Human Pancreatic Cancer Model
CLAIRE M. MACH, LATA MATHEW, SCOTT A. MOSLEY, RAZELLE KURZROCK, JUDITH A. SMITH
Anticancer Research Jun 2009, 29 (6) 1895-1899;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Plasma concentrations of curcumin in individuals using curcumin with adjuvants or lipid formulated curcumin supplements: a real world cohort
  • Containing Cancer with Personalized Minimum Effective Dose
  • Efficacy of Liposomal Curcumin in a Human Pancreatic Tumor Xenograft Model: Inhibition of Tumor Growth and Angiogenesis
  • Combining Curcumin (Diferuloylmethane) and Heat Shock Protein Inhibition for Neurofibromatosis 2 Treatment: Analysis of Response and Resistance Pathways
  • Evaluation of Liposomal Curcumin Cytochrome P450 Metabolism
  • Google Scholar

More in this TOC Section

  • Expression of YAP1 and TAZ in Melanoma-, Bronchial- and Breast Carcinoma Brain Metastasis: Primary vs. Relapsed Tumors
  • Correlation Analysis Between IFIT2 and HLA Class II in Oral Cancer
  • Combination of Recombinant Methioninase With Rapamycin or Chloroquine Is Synergistic to Highly Inhibit Triple-negative Breast Cancer Cells In Vitro
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire